Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Fox

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'A D Michelson, M D Linden, M I Furman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantationM L Fox, P Barba, I Heras, et al.
Journal of the American College of Cardiology|October 5, 2001
Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarctionM I Furman, M R Barnard, L A Krueger, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activitiesA L Frelinger, J A Jakubowski, Y Li, et al.
American Heart Journal|October 31, 2001
Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximabM I Furman, D J Kereiakes, L A Krueger, et al.
Depression and Anxiety|August 2, 2017
Examining the diagnostic utility of the DSM-5 PTSD symptoms among male and female returning veteransJonathan D Green, Anthony Annunziata, Sarah E Kleiman, et al.
Leukemia|September 23, 2017
Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosisJ-C Hernández-Boluda, A Pereira, J-G Correa, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'A D Michelson, M D Linden, M I Furman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 2015
A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantationM L Fox, P Barba, I Heras, et al.
Journal of the American College of Cardiology|October 5, 2001
Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarctionM I Furman, M R Barnard, L A Krueger, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activitiesA L Frelinger, J A Jakubowski, Y Li, et al.
American Heart Journal|October 31, 2001
Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximabM I Furman, D J Kereiakes, L A Krueger, et al.
Depression and Anxiety|August 2, 2017
Examining the diagnostic utility of the DSM-5 PTSD symptoms among male and female returning veteransJonathan D Green, Anthony Annunziata, Sarah E Kleiman, et al.
Leukemia|September 23, 2017
Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosisJ-C Hernández-Boluda, A Pereira, J-G Correa, et al.
Pageof 4